- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01528215
Multicenter Study Comparing OsseoSpeed TX With OsseoSpeed EV.
April 9, 2020 updated by: Dentsply Sirona Implants
An Open, Prospective, Randomized, Multicenter Study Comparing OsseoSpeed™ EV With OsseoSpeed™ TX in Partially Edentulous Maxillae and Mandibles. A 5-year Follow-up Study.
The purpose of this study is to evaluate the outcome of implant OsseoSpeed EV compared to implant OsseoSpeed TX with regards to marginal bone level changes and implant survival rate up to five years after implant loading.
The hypothesis is that there will be no clinically relevant differences in marginal bone level alterations one year after functional loading.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ghent, Belgium, 9000
- University Hospital Ghent, Dental School Department Periodontology
-
-
-
-
-
Frankfurt am Main, Germany, 605 90
- Dep. of Prosthodontics, Goethe University
-
-
-
-
-
Padova, Italy, 351 25
- Dental private practice, Denis Cecchinato
-
-
-
-
Iowa
-
Iowa City, Iowa, United States, 52242-1010
- Dows Institute for Dental Research, University of Iowa, College of Dentistry
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Provision of Informed Consent.
- 18 -75 years at enrollment.
- In need of implant(s) replacing missing tooth/teeth in the maxilla or in the mandible (no edentulous jaws).
- History of edentulism in the planned implant area of at least 3 months (at Visit 2).
- At least 4 months of healing after last grafting procedure in the planned implant area (at Visit 2).
- Deemed by the investigator to be suitable for one stage surgery and be likely to present an initially stable implant situation i.e. have a bone height and bone width suitable for the chosen study implants.
- Deemed by the investigator to be suitable for loading after 6-8 weeks.
- Deemed by the investigator to have a "functional" opposing dentition at the time of loading the implants i.e. an even distribution of contacts between the teeth in the opposite jaw and the planned permanent crown/bridge.
Exclusion Criteria:
- Unlikely to be able to comply with study procedures, as judged by the investigator.
- Uncontrolled pathological processes in the oral cavity.
- Untreated, uncontrolled caries and/or periodontal disease.
- Known or suspected current malignancy.
- History of radiation therapy in the head and neck region.
- History of chemotherapy within 5 years prior to surgery.
- Systemic or local disease or condition that would compromise post-operative healing and/or osseointegration, as deemed by the investigator.
- Uncontrolled diabetes mellitus.
- Corticosteroids or any other medication that would compromise post-operative healing and/or osseointegration.
- Smoking more than 10 cigarettes per day.
- Present alcohol and/or drug abuse.
- Current need for bone grafting and/or augmentation in the planned implant area. Local, minor soft tissue grafting will be allowed.
- Involvement in the planning and conduct of the study (applies to both Astra Tech staff and staff at the study site).
- Previous enrollment in the present study.
- Simultaneous participation in other clinical studies at enrollment (Visit 1) and during the subject's first year of this study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: OsseoSpeed EV
OsseoSpeed EV implants; Ø 3.6, 4.2, 4.8 mm in lengths of 9,11 and 13 mm
|
OsseoSpeed EV implants; Ø 3.6, 4.2, 4.8 mm in lengths of 9,11 and 13 mm
|
ACTIVE_COMPARATOR: OsseoSpeed TX
OsseoSpeed TX implants; Ø 3.5, 4.0 and 5.0 mm in lengths of 9,11 and 13 mm
|
OsseoSpeed TX implants; Ø 3.5, 4.0 and 5.0 mm in lengths of 9,11 and 13 mm
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Marginal Bone Level Change After 1 Year in Use.
Time Frame: Evaluated at implant loading and at the 1 year follow-up after implant loading.
|
Marginal bone level will be determined from radiographs and expressed as the distance from a reference point on the implant to the most coronal bone-to-implant contact on the mesial and distal aspect of the implant.
Marginal bone level expressed in millimeters at the 1 year follow-up visit compared to values obtained at delivery of permanent restoration i.e. loading (baseline).
Positive value = bone gain, Negative value = bone loss.
|
Evaluated at implant loading and at the 1 year follow-up after implant loading.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Marginal Bone Level Change After 5 Years in Use.
Time Frame: Evaluated from implant loading to the 5 years follow-up after implant loading.
|
Marginal bone level will be determined from radiographs and expressed as the distance from a reference point on the implant to the most coronal bone-to-implant contact on the mesial and distal aspect of the implant.
Marginal bone level expressed in millimeters at the 5 years follow-up visit compared to values obtained at delivery of permanent restoration i.e. loading (baseline).
|
Evaluated from implant loading to the 5 years follow-up after implant loading.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Clark M Stanford, Prof, University of Illinois at Chicago, College of Dentistry
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2011
Primary Completion (ACTUAL)
June 1, 2014
Study Completion (ACTUAL)
April 1, 2018
Study Registration Dates
First Submitted
February 3, 2012
First Submitted That Met QC Criteria
February 3, 2012
First Posted (ESTIMATE)
February 7, 2012
Study Record Updates
Last Update Posted (ACTUAL)
April 22, 2020
Last Update Submitted That Met QC Criteria
April 9, 2020
Last Verified
April 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- OTX-PLUS-0001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Partial Edentulism in the Maxilla or in the Mandible
-
University of MichiganBioHorizons, Inc.CompletedDental Implant Soft Tissue Defects in the Anterior MaxillaUnited States
-
Jeder GmbHUnknownInsufficient Bone Mass in the Maxilla for Dental ImplantsAustria
-
St. Vincent's Medical CenterUnknownThis Study Has Been Designed to Compile Information on the Efficacy of the Partial Breast Intracavitary Brachytherapy in the Post Market Setting.United States
-
Pusan National University Yangsan HospitalCompletedExtubation in the OR After LDLTKorea, Republic of
-
Copenhagen Trial Unit, Center for Clinical Intervention...The Info Trial Group; Charlotte Behnke; Pia Caspersen; Dorte Fischer; Rolf I. Hansen and other collaboratorsCompletedAmbulatory Patients in the Dep. of Medical Gastroenterology | Ambulatory Patients in the Dep. of Gynecology | Ambulatory Patients in the Dep. of Orthopedic Surgery | Ambulatory Patients in the Dep. of UrologyDenmark
-
Suranaree University of TechnologyCompletedThe Phenomenon of the Decrease in the Electrical Resistance Within the Conducting Chambers, Making the Increase in a Conducting PropertyThailand
-
Memorial Sloan Kettering Cancer CenterCompletedMetastatic or Recurrent Lesions in the Spine | Metastatic or Recurrent Lesions in the PelvisUnited States
-
Meshalkin Research Institute of Pathology of CirculationNot yet recruitingthe Strength Properties of the Aorta in Vivo | the Strength Properties of the Aorta in Vitro | Regression Model of Aortic Strength Properties in Vitro and in VitroRussian Federation
-
Coram Clinical TrialsCompletedIVIg or SCIg Therapy in the Home or at Alternate SiteUnited States
-
Chulalongkorn UniversityCompletedThe Retention of Iodine in Saliva Over the Time | The Comparison of Iodine in Saliva Between Gargle and SwabThailand
Clinical Trials on OsseoSpeed EV
-
Dentsply Sirona Implants and ConsumablesCompletedDental ImplantsUnited States, Belgium, Canada, Finland, Germany, Sweden
-
University Medical Center GroningenNot yet recruitingEdentulous Alveolar Ridge
-
Dentsply Sirona Implants and ConsumablesCompletedPartial Edentulism | Edentulism NosSweden
-
Dentsply Sirona Implants and ConsumablesCompletedOsteopenia | Jaw, Edentulous, Partially | Postmenopausal OsteoporosisBelgium, Germany, Sweden
-
Dentsply Sirona Implants and ConsumablesCompleted
-
Dentsply Sirona Implants and ConsumablesCompletedJaw, Edentulous, PartiallyUnited States, Germany
-
Dentsply Sirona Implants and ConsumablesCompletedJaw, Edentulous, PartiallyItaly, Spain, Switzerland
-
Dentsply Sirona Implants and ConsumablesCompletedJaw, Edentulous, PartiallyUnited States, Germany
-
Dentsply Sirona Implants and ConsumablesCompletedPartially Edentulous JawChina
-
Grupo de Investigação: Cirurgia Oral, Peridontologia...Universidade do Porto; Dentsply Sirona Implants and Consumables; Tecnoss OsteoBiolCompletedDental Implant Survival RatePortugal